Pawelec G, Adibzadeh M, Solana R, Beckman I
Second Department of Internal Medicine, University of Tübingen Medical School, Germany.
Mech Ageing Dev. 1997 Feb;93(1-3):35-45. doi: 10.1016/s0047-6374(96)01812-x.
Aged persons frequently manifest declining parameters of those immune functions which protect the young against disease. Longitudinal studies are beginning to show that number, type and function of T cells may be associated with longevity, morbidity and mortality in free-living elderly humans. Multi-faceted alterations in the ability of T cells from old donors to respond to stimulation are being dissected, and pathways which are compromized in the elderly compared to the young are being defined. Successful immune responses depend upon waves of rapid and extensive clonal expansion to combat primary infection, followed by death of most T cells, survival of memory cells and their later reactivation and further expansion. This implies that the finite replicative potential of T cells might impose a critical limiting factor on the maintenance of immune responses in the face of thymic involution and drastically reduced capacity to generate new naive T cells. This type of 'clonal exhaustion' can readily be studied in vitro using human T cell clones and the findings can be applied to the in vivo situation. Understanding the processes of replicative senescence in such in vitro models may shed light not only on some of the underlying mechanisms of immunosenescence but also in situations of chronic antigenic stimulation in vivo. Moreover, it might begin to indicate how the system could be manipulated on the one hand to prevent or reverse T cell senescence without nullifying the control mechanisms of tumor suppression, and on the other hand, to reconstitute possibly faulty suppression, for example in autoimmune disease.
老年人常常表现出那些保护年轻人抵御疾病的免疫功能参数下降。纵向研究开始表明,T细胞的数量、类型和功能可能与自由生活的老年人的长寿、发病率和死亡率有关。来自老年供体的T细胞对刺激作出反应的能力的多方面改变正在被剖析,与年轻人相比,老年人中受损的途径正在被明确。成功的免疫反应依赖于一波又一波快速而广泛的克隆扩增以对抗原发性感染,随后大多数T细胞死亡,记忆细胞存活,以及它们随后的重新激活和进一步扩增。这意味着T细胞有限的复制潜能可能会成为面对胸腺退化和产生新的幼稚T细胞的能力急剧下降时维持免疫反应的一个关键限制因素。这种类型的“克隆耗竭”可以很容易地在体外使用人T细胞克隆进行研究,并且研究结果可以应用于体内情况。了解此类体外模型中的复制性衰老过程不仅可能揭示免疫衰老的一些潜在机制,还能揭示体内慢性抗原刺激的情况。此外,它可能开始表明一方面如何在不破坏肿瘤抑制控制机制的情况下操纵该系统以预防或逆转T细胞衰老,另一方面如何重建可能存在缺陷的抑制,例如在自身免疫性疾病中。